-
Net income for the
September 2017 quarter was$110 million ($0.81 per diluted share) compared to$77 million ($0.61 per diluted share) in the prior year quarter. Adjusted net income per diluted share in theSeptember 2017 quarter was 19 percent higher at$0.87 compared to$0.73 in the prior year quarter. -
Net sales increased 16 percent over the prior year quarter to
$1.9 billion . Operating income for the quarter increased by 32 percent to$199 million compared to$151 million in the prior year quarter. Operating EBITDA was$350 million (18.6 percent of net sales), an increase of 16 percent compared to theSeptember 2016 quarter. -
Fiscal year 2017 net sales increased 9 percent over the prior fiscal
year to
$7.1 billion compared to$6.5 billion . Operating income for fiscal year 2017 increased by 26 percent to$732 million compared to$581 million in the prior fiscal year. Operating EBITDA was a fiscal year record at$1.33 billion (18.7 percent of net sales), an increase of 10 percent compared to$1.21 billion (18.6 percent of net sales) in fiscal year 2016. -
Cash flow from operations for fiscal 2017 was
$975 million , and adjusted free cash flow for fiscal 2017 was a fiscal year record at$601 million . -
Expected fiscal year 2018 cash flow from operations of
$965 million and adjusted free cash flow of$610 million .
“Berry had a solid fourth quarter and full fiscal year as we exceeded
our guidance for adjusted free cash flow by
Consolidated Overview | ||||||||||||
September Quarterly Period Ended | ||||||||||||
(in millions of dollars) | 2017 | 2016 |
$ Change |
% Change |
||||||||
Net sales | $ | 1,881 | $ | 1,618 | $ | 263 | 16 | % | ||||
Operating income | 199 | 151 | 48 | 32 | % | |||||||
The net sales increase of
The operating income increase of
Fiscal Year 2017 Results
Consolidated Overview | ||||||||||||
Fiscal Year | ||||||||||||
(in millions of dollars) | 2017 | 2016 |
$ Change |
% Change |
||||||||
Net sales | $ | 7,095 | $ | 6,489 | $ | 606 | 9 | % | ||||
Operating income | 732 | 581 | 151 | 26 | % | |||||||
The net sales increase of
The operating income increase of
The performance of the Company’s divisions compared with the prior fiscal year is as follows:
Engineered Materials | ||||||||||||
Fiscal Year | ||||||||||||
(in millions of dollars) | 2017 | 2016 |
$ Change |
% Change | ||||||||
Net sales | $ | 2,375 | $ | 1,627 | $ | 748 | 46 | % | ||||
Operating income | 316 | 183 | 134 | 74 | % | |||||||
Engineered Materials’ net sales increased by
The operating income increase of
Health, Hygiene, and Specialties | |||||||||||||
Fiscal Year | |||||||||||||
(in millions of dollars) | 2017 | 2016 |
$ Change |
% Change |
|||||||||
Net sales | $ | 2,369 | $ | 2,400 | $ | (31 | ) | (1 | )% | ||||
Operating income | 216 | 195 | 21 | 11 | % | ||||||||
Health, Hygiene, and Specialties’ net sales decreased by
The operating income increase of
Consumer Packaging | |||||||||||||
Fiscal Year | |||||||||||||
(in millions of dollars) | 2017 | 2016 |
$ Change |
% Change |
|||||||||
Net sales | $ | 2,351 | $ | 2,462 | $ | (111 | ) | (5 | )% | ||||
Operating income | 200 | 203 | (3 | ) | (1 | )% | |||||||
Consumer Packaging’s net sales decreased by
The operating income decrease of
Cash Flow and Capital Structure
Our cash flow from operating activities was
Our total debt less cash and cash equivalents at the end of the
Earlier today,
Outlook
We anticipate our fiscal year 2018 cash flow from operations and
adjusted free cash flow to be
Investor Conference Call
The Company will host a conference call today,
About Berry
Berry is committed to its mission of ‘Always Advancing to Protect What’s
Important,’ and proudly partners with its customers to provide them with
value-added customized protection solutions. The Company’s products
include engineered materials, non-woven specialty materials, and
consumer packaging. Berry’s world headquarters is located in
Non-GAAP Financial Measures
This press release includes non-GAAP financial measures such as
operating EBITDA, adjusted EBITDA, adjusted net income, adjusted free
cash flow, and cash interest expense. A reconciliation of these non-GAAP
financial measures to comparable measures determined in accordance with
accounting principles generally accepted in
Forward Looking Statements
Statements in this release that are not historical, including statements relating to the expected future performance of the Company, are considered “forward looking” and are presented pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You can identify forward-looking statements because they contain words such as “believes,” “expects,” “may,” “will,” “should,” “would,” “could,” “seeks,” “approximately,” “intends,” “plans,” “estimates,” “anticipates” “outlook,” or “looking forward,” or similar expressions that relate to our strategy, plans or intentions. All statements we make relating to our estimated and projected earnings, margins, costs, expenditures, cash flows, growth rates and financial results or to our expectations regarding future industry trends are forward-looking statements. In addition, we, through our senior management team, from time to time make forward-looking public statements concerning our expected future operations and performance and other developments. These forward-looking statements are subject to risks and uncertainties that may change at any time, and, therefore, our actual results may differ materially from those that we expected.
Important factors that could cause actual results to differ
materially from our expectations, which we refer to as cautionary
statements, are disclosed under “Risk Factors” and elsewhere in our
Annual Report on Form 10-K and subsequent filings with the
Berry Global Group, Inc. | |||||||||||||||
Consolidated Statements of Income | |||||||||||||||
(Unaudited) |
|||||||||||||||
(in millions of dollars, except per share data amounts) |
|||||||||||||||
Quarterly Period Ended | Fiscal Year Ended | ||||||||||||||
September 30, |
October 1, |
September 30, |
October 1, |
||||||||||||
Net sales | $ | 1,881 | $ | 1,618 | $ | 7,095 | $ | 6,489 | |||||||
Costs and expenses: | |||||||||||||||
Cost of goods sold | 1,514 | 1,317 | 5,691 | 5,202 | |||||||||||
Selling, general and administrative | 121 | 110 | 494 | 531 | |||||||||||
Amortization of intangibles | 41 | 37 | 154 | 143 | |||||||||||
Restructuring and impairment charges | 6 | 3 | 24 | 32 | |||||||||||
Operating income | 199 | 151 | 732 | 581 | |||||||||||
Other (income) expense, net | (4 | ) | (1 | ) | 14 | (18 | ) | ||||||||
Interest expense, net | 66 | 69 | 269 | 291 | |||||||||||
Income before income taxes | 137 | 83 | 449 | 308 | |||||||||||
Income tax expense | 27 | 6 | 109 | 72 | |||||||||||
Consolidated net income | $ | 110 | $ | 77 | $ | 340 | $ | 236 | |||||||
Net income per share: | |||||||||||||||
Basic | $ | 0.84 | $ | 0.63 | $ | 2.66 | $ | 1.95 | |||||||
Diluted | 0.81 | 0.61 | 2.56 | 1.89 | |||||||||||
Outstanding weighted-average shares: (in millions) | |||||||||||||||
Basic | 130.6 | 121.7 | 127.6 | 120.8 | |||||||||||
Diluted | 135.7 | 127.1 | 132.6 | 125.0 | |||||||||||
Berry Global Group, Inc. | ||||||||||||||||
Consolidated Statements of Comprehensive Income | ||||||||||||||||
(Unaudited) |
||||||||||||||||
(in millions of dollars) |
||||||||||||||||
Quarterly Period Ended | Fiscal Year Ended | |||||||||||||||
September 30, |
October 1, |
September 30, |
October 1, |
|||||||||||||
Consolidated net income | $ | 110 | $ | 77 | $ | 340 | $ | 236 | ||||||||
Currency translation | 30 | (40 | ) | 34 | (1 | ) | ||||||||||
Defined benefit pension and retiree health benefit plans | 25 | (23 | ) | 38 | (23 | ) | ||||||||||
Interest rate hedges | 5 | 6 | 28 | (14 | ) | |||||||||||
Provision for income taxes related to other comprehensive income items | (12 | ) | 1 | (20 | ) | 9 | ||||||||||
Other comprehensive income, net of tax | 48 | (56 | ) | 80 | (29 | ) | ||||||||||
Comprehensive income | $ | 158 | $ | 21 | $ | 420 | $ | 207 | ||||||||
Berry Global Group, Inc. | ||||||
Condensed Consolidated Balance Sheets | ||||||
(Unaudited) |
||||||
(in millions of dollars) |
||||||
September 30, |
October 1, |
|||||
Assets: | ||||||
Cash and cash equivalents | $ | 306 | $ | 323 | ||
Accounts receivable, net | 847 | 704 | ||||
Inventories | 762 | 660 | ||||
Other current assets | 89 | 105 | ||||
Property, plant, and equipment, net | 2,366 | 2,224 | ||||
Goodwill, intangible assets, and other long-term assets | 4,106 | 3,637 | ||||
Total assets | $ | 8,476 | $ | 7,653 | ||
Liabilities and stockholders' equity: | ||||||
Current liabilities, excluding debt | $ | 1,101 | $ | 988 | ||
Current and long-term debt | 5,641 | 5,755 | ||||
Other long-term liabilities | 719 | 689 | ||||
Stockholders’ equity | 1,015 | 221 | ||||
Total liabilities and stockholders' equity | $ | 8,476 | $ | 7,653 | ||
Current and Long-Term Debt |
||||||||
September 30, |
October 1, |
|||||||
(in millions of dollars) | ||||||||
Revolving line of credit | $ | — | $ | — | ||||
Term loans | 3,957 | 4,060 | ||||||
5.5% Second priority notes | 500 | 500 | ||||||
6.0% Second priority notes | 400 | 400 | ||||||
5.125% Second priority notes | 700 | 700 | ||||||
Debt discounts and deferred fees | (48 | ) | (58 | ) | ||||
Capital leases and other | 132 | 153 | ||||||
Total debt | $ | 5,641 | $ | 5,755 | ||||
Berry Global Group, Inc. | ||||||||
Condensed Consolidated Statements of Cash Flows | ||||||||
(Unaudited) |
||||||||
(in millions of dollars) |
||||||||
Fiscal Year Ended | ||||||||
September 30, |
October 1, |
|||||||
Cash flows from operating activities: | ||||||||
Consolidated net income | $ | 340 | $ | 236 | ||||
Depreciation | 367 | 382 | ||||||
Amortization of intangibles | 154 | 143 | ||||||
Other non-cash items | 59 | 51 | ||||||
Working capital | 55 | 45 | ||||||
Net cash from operating activities | 975 | 857 | ||||||
Cash flows from investing activities: | ||||||||
Additions to property, plant, and equipment | (269 | ) | (288 | ) | ||||
Proceeds from sale of assets | 6 | 5 | ||||||
Other investing activities, net | 4 | (13 | ) | |||||
Acquisitions of businesses, net of cash acquired | (515 | ) | (2,283 | ) | ||||
Net cash from investing activities | (774 | ) | (2,579 | ) | ||||
Cash flows from financing activities: | ||||||||
Proceeds from long-term borrowings | 495 | 2,490 | ||||||
Repayment of long-term borrowings | (636 | ) | (524 | ) | ||||
Proceeds from issuance of common stock | 31 | 26 | ||||||
Debt financing costs | (5 | ) | (40 | ) | ||||
Payment of tax receivable agreement | (111 | ) | (57 | ) | ||||
Purchase of non-controlling interest | — | (78 | ) | |||||
Net cash from financing activities | (226 | ) | 1,817 | |||||
Effect of exchange rate changes on cash | 8 | — | ||||||
Net change in cash and cash equivalents | (17 | ) | 95 | |||||
Cash and cash equivalents at beginning of period | 323 | 228 | ||||||
Cash and cash equivalents at end of period | $ | 306 | $ | 323 | ||||
Berry Global Group, Inc. |
||||||||||||
Condensed Consolidated Financial Statements |
||||||||||||
Segment Information |
||||||||||||
(Unaudited) |
||||||||||||
(in millions of dollars) |
||||||||||||
Quarterly Period Ended September 30, 2017 | ||||||||||||
Consumer |
Health, Hygiene |
Engineered |
Total | |||||||||
Net sales | $ | 599 | $ | 596 | $ | 686 | $ | 1,881 | ||||
Operating income | $ | 50 | $ | 52 | $ | 97 | $ | 199 | ||||
Depreciation and amortization | 57 | 48 | 33 | 138 | ||||||||
Restructuring and impairment charges | 2 | 3 | 1 | 6 | ||||||||
Other non-cash charges (1) | 2 | 2 | 2 | 6 | ||||||||
Business optimization costs (2) | — | 1 | — | 1 | ||||||||
Operating EBITDA | $ | 111 | $ | 106 | $ | 133 | $ | 350 | ||||
Quarterly Period Ended October 1, 2016 |
||||||||||||
Consumer |
Health, Hygiene |
Engineered |
Total | |||||||||
Net sales | $ | 617 | $ | 593 | $ | 408 | $ | 1,618 | ||||
Operating income | $ | 47 | $ | 55 | $ | 49 | $ | 151 | ||||
Depreciation and amortization | 61 | 56 | 18 | 135 | ||||||||
Restructuring and impairment charges | 2 | — | 1 | 3 | ||||||||
Other non-cash charges (1) | 2 | 2 | 2 | 6 | ||||||||
Business optimization costs (2) | 1 | 4 | 1 | 6 | ||||||||
Operating EBITDA | $ | 113 | $ | 117 | $ | 71 | $ | 301 | ||||
(1) | Other non-cash charges in the September 2017 quarter primarily includes $4 million of stock compensation expense. Other non-cash charges in the September 2016 quarter primarily includes $3 million of stock compensation expense along with other non-cash charges. | |
(2) | Includes integration expenses and other business optimization costs. | |
Berry Global Group, Inc. | ||||||||||||
Condensed Consolidated Financial Statements | ||||||||||||
Segment Information | ||||||||||||
(Unaudited) |
||||||||||||
(in millions of dollars) |
||||||||||||
Fiscal Year Ended September 30, 2017 |
||||||||||||
Consumer |
Health, Hygiene |
Engineered |
Total | |||||||||
Net sales | $ | 2,351 | $ | 2,369 | $ | 2,375 | $ | 7,095 | ||||
Operating income | $ | 200 | $ | 216 | $ | 316 | $ | 732 | ||||
Depreciation and amortization | 231 | 184 | 106 | 521 | ||||||||
Restructuring and impairment charges | 8 | 11 | 5 | 24 | ||||||||
Other non-cash charges (1) | 10 | 12 | 12 | 34 | ||||||||
Business optimization costs (2) | — | 11 | 5 | 16 | ||||||||
Operating EBITDA | $ | 449 | $ | 434 | $ | 444 | $ | 1,327 | ||||
Fiscal Year Ended October 1, 2016 |
||||||||||||
Consumer |
Health, Hygiene |
Engineered |
Total | |||||||||
Net sales | $ | 2,462 | $ | 2,400 | $ | 1,627 | $ | 6,489 | ||||
Operating income | $ | 203 | $ | 195 | $ | 183 | $ | 581 | ||||
Depreciation and amortization | 244 | 199 | 82 | 525 | ||||||||
Restructuring and impairment charges | 9 | 20 | 3 | 32 | ||||||||
Other non-cash charges (1) | 11 | 18 | 12 | 41 | ||||||||
Business optimization costs (2) | 3 | 25 | 3 | 31 | ||||||||
Operating EBITDA | $ | 470 | $ | 457 | $ | 283 | $ | 1,210 | ||||
(1) | Other non-cash charges for the fiscal year ended September 30, 2017 primarily include $20 million of stock compensation expense, $5 million step up of inventory to fair value related to the AEP acquisition, along with other non-cash charges. Other non-cash charges for the fiscal year ended October 1, 2016 primarily includes $20 million of stock compensation expense, $7 million step-up of inventory to fair value related to the Avintiv acquisition and other non-cash charges. | |
(2) | Includes integration expenses and other business optimization costs. | |
Berry Global Group, Inc. |
||||||||||||||||
Reconciliation Schedules |
||||||||||||||||
(Unaudited) |
||||||||||||||||
(in millions of dollars, except per share data) |
||||||||||||||||
Quarterly Period Ended | Fiscal Year Ended | |||||||||||||||
September 30, |
October 1, |
September 30, |
October 1, |
|||||||||||||
Consolidated net income | $ | 110 | $ | 77 | $ | 340 | $ | 236 | ||||||||
Add: other expense (income), net | (4 | ) | (1 | ) | 14 | (18 | ) | |||||||||
Add: interest expense, net | 66 | 69 | 269 | 291 | ||||||||||||
Add: income tax expense | 27 | 6 | 109 | 72 | ||||||||||||
Operating income | $ | 199 | $ | 151 | $ | 732 | $ | 581 | ||||||||
Add: non-cash amortization from 2006 private sale | 8 | 8 | 32 | 32 | ||||||||||||
Add: restructuring and impairment | 6 | 3 | 24 | 32 | ||||||||||||
Add: other non-cash charges (1) | 6 | 6 | 34 | 41 | ||||||||||||
Add: business optimization and other expenses (2) | 1 | 6 | 16 | 31 | ||||||||||||
Adjusted operating income (9) | $ | 220 | $ | 174 | $ | 838 | $ | 717 | ||||||||
Add: depreciation | 97 | 98 | 367 | 382 | ||||||||||||
Add: amortization of intangibles (3) | 33 | 29 | 122 | 111 | ||||||||||||
Operating EBITDA (9) | $ | 350 | $ | 301 | $ | 1,327 | $ | 1,210 | ||||||||
Add: acquisitions (4) | 35 | — | ||||||||||||||
Add: unrealized cost savings (5) | 43 | 10 | ||||||||||||||
Adjusted EBITDA (9) | $ | 1,405 | $ | 1,220 | ||||||||||||
Cash flow from operating activities |
$ |
395 |
$ |
290 |
$ |
975 |
$ |
857 |
||||||||
Net additions to property, plant, and equipment | (66 | ) | (59 | ) | (263 | ) | (283 | ) | ||||||||
Payment of tax receivable agreement | (51 | ) | — | (111 | ) | (57 | ) | |||||||||
Adjusted free cash flow (9) | $ | 278 | $ | 231 | $ | 601 | $ | 517 | ||||||||
Net income per diluted share |
$ |
0.81 |
$ |
0.61 |
$ |
2.56 |
$ |
1.89 |
||||||||
Other expense (income), net | (0.03 | ) | (0.01 | ) | 0.11 | (0.15 | ) | |||||||||
Non-cash amortization from 2006 private sale | 0.06 | 0.06 | 0.24 | 0.26 | ||||||||||||
Restructuring and impairment | 0.04 | 0.02 | 0.18 | 0.26 | ||||||||||||
Other non-cash charges (6) | 0.01 | 0.05 | 0.10 | 0.32 | ||||||||||||
Business optimization costs (2) | 0.01 | 0.05 | 0.12 | 0.25 | ||||||||||||
Income tax impact on items above (7) | (0.03 | ) | (0.05 | ) | (0.24 | ) | (0.30 | ) | ||||||||
Adjusted net income per diluted share (9) | $ | 0.87 | $ | 0.73 | $ | 3.07 | $ | 2.53 | ||||||||
Estimated |
||||||||||||||||
Cash flow from operating activities |
$ |
965 |
||||||||||||||
Additions to property, plant, and equipment |
(320 |
) |
||||||||||||||
Tax receivable agreement payment (8) |
(35 |
) |
||||||||||||||
Adjusted free cash flow (9) |
$ |
610 |
||||||||||||||
Interest expense |
255 |
|||||||||||||||
Additions to property, plant, and equipment |
(5 |
) |
||||||||||||||
Cash interest expense (9) |
$ |
250 |
||||||||||||||
|
Clopay Reconciliation Schedule | |||
(Unaudited) |
|||
Fiscal Year 2017 | |||
Segment operating income | $ | 25 | |
Depreciation and amortization | 28 | ||
Segment operating EBITDA | 53 | ||
Berry’s expected annual cost synergies | 20 | ||
Adjusted EBITDA | $ | 73 | |
(1) | Other non-cash charges in the September 2017 quarter primarily include $4 million of stock compensation expense and other non-cash charges. The September 2016 quarter primarily includes $3 million of stock compensation expense and other non-cash charges. For the fiscal year ended September 2017 other non-cash charges primarily include $20 million of stock compensation expense, $5 million step-up of inventory to fair value related to the AEP Industries Inc. acquisition and other non-cash charges. Other non-cash charges for the fiscal year ended October 1, 2016 primarily includes $20 million of stock compensation expense, $7 million step-up of inventory to fair value related to the Avintiv acquisition and other non-cash charges. | ||
(2) | Includes integration expenses and other business optimization costs. | ||
(3) | Amortization excludes non-cash amortization from the 2006 private sale of $8 million for both the September 30, 2017 and October 1, 2016 quarters and $32 million for the both the four quarters ended September 30, 2017 and October 1, 2016. | ||
(4) | Represents Operating EBITDA for the AEP acquisition for the period of October 2016 to January 19, 2017 and the Adchem acquisition for the period of October 2016 to June 2017. | ||
(5) | Primarily represents unrealized cost savings related to acquisitions. | ||
(6) | Other non-cash charges excludes $4 million and $20 million of stock compensation expense for the quarter ended September 30, 2017 and fiscal year end 2017, respectively. Prior year quarter and fiscal year impact on adjusted net income per share would be $0.02 and $0.11, respectively. | ||
(7) | Income tax effects on adjusted net income were calculated using 32% for both the September 2017 and 2016 quarters and fiscal years. The rates used for each represents the Company’s expected effective tax rate for each respective period. | ||
(8) | Includes $35 million tax receivable agreement payment to be made in our first fiscal quarter in 2018. | ||
(9) | Supplemental financial measures that are not required by, or presented in accordance with, accounting principles generally accepted in the United States (“GAAP”). These non-GAAP financial measures should not be considered as alternatives to operating or net income or cash flows from operating activities, in each case determined in accordance with GAAP. These non-GAAP financial measures may be calculated differently by other companies, including other companies in our industry, limiting their usefulness as comparative measures. | ||
Our projected adjusted free cash flow for fiscal 2018 assumes $965 million of cash flow from operations less $320 million of net additions to property, plant, and equipment and $35 million of payments under our tax receivable agreement. We define “adjusted free cash flow” as cash flow from operating activities less additions to property, plant, and equipment and payments under the tax receivable agreement. We believe adjusted free cash flow is useful to an investor in evaluating our liquidity because adjusted free cash flow and similar measures are widely used by investors, securities analysts, and other interested parties in our industry to measure a company’s liquidity. We also believe adjusted cash flow is useful to an investor in evaluating our liquidity as it can assist in assessing a company’s ability to fund its growth through its generation of cash. We believe cash interest expense is useful to investors by providing information regarding interest expense without regard to non-cash interest expense recognition which may vary based on financing structure and accounting methods. | |||
Adjusted EBITDA is used by our lenders for debt covenant compliance purposes. We also use Adjusted EBITDA and Operating EBITDA among other measures to evaluate management performance and in determining performance-based compensation. Adjusted EBITDA and Operating EBITDA and similar measures are widely used by investors, securities analysts, and other interested parties in our industry to measure a company’s performance. We also believe EBITDA and adjusted net income are useful to an investor in evaluating our performance without regard to revenue and expense recognition, which can vary depending upon accounting methods. The Clopay reconciliation schedule for segment operating EBITDA, is not a measure determined in accordance with accounting principles generally accepted in the United States of America (GAAP). For further information regarding Clopay’s results, including a reconciliation of non-GAAP financial measures to comparable GAAP measures, see the earnings release of Griffin Corporation issued earlier today. As used herein, Clopay’s operating EBITDA refers to the same measure defined in Griffin Corporation’s earnings release as Clopay’s “Segment operating EBITDA.” Non-GAAP measures should be viewed as supplements to, rather than substitutes for comparable measures under GAAP. | |||
View source version on businesswire.com: http://www.businesswire.com/news/home/20171116005316/en/
Source:
Berry Global Group, Inc.
Dustin Stilwell, +1-812-306-2964
ir@berryglobal.com